Return of de-differentiation: Why cancer is a developmental disease

Current Opinion in Oncology

Volumn 13, Issue 1, 2001, Pages 58-62

  Da Costa, Luís Filipe Teixeira ^a  

^a UNIVERSITY OF BEIRA INTERIOR   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER; CARCINOGENESIS; CELL DIFFERENTIATION; DEVELOPMENTAL DISORDER; GENE MUTATION; HUMAN; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; REVIEW;

CELL DIFFERENTIATION; CELL TRANSFORMATION, NEOPLASTIC; EVOLUTION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MODELS, THEORETICAL; NEOPLASMS; PHENOTYPE;

EID: 0035170504     PISSN: 10408746     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001622-200101000-00012     Document Type: Review

References (39)

1. The clonal evolution of tumor cell populations
2. Nature of malignant tumors
3. Recent advances in research on multistage tumorigenesis
4. The hallmarks of cancer
5. Cancer as a dynamic developmental disorder
6. Teratomas and chimeras
7. Reversion of malignancy and normalized dedifferentiation of teratocarcinoma cells in chimeric mice
8. Think globally, act locally: The making of a mouse mammary gland
9. Acute promyelocytic leukemia. From morphology to molecular lesions
10. Role of the transcription factor AML-1 in acute leukemia and hematopoietic differentiation
11. New strategies for the treatment of acute myelogenous leukemia: Differentiation induction - Present use and future possibilities
12. Reprogramming erythroleukemia cells to terminal differentiation and terminal cell division
13. Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation
14. Mammary gland oncogenes as indicators of pathways important in mammary gland development
15. Mammary gland specific hEGF receptor transgene expression induces neoplasia and inhibits differentiation
16. Mice heterozygous for a Brca1 or Brca2 mutation display distinct mammary gland and ovarian phenotypes in response to diethylstilbestrol
17. Identification of FAP locus genes from chromosome 5q21
18. Mutations of the adenomatous potyposis coli gene in familial polyposis coli patients and sporadic colorectal tumors
19. APC mutations occur early during colorectal tumorigenesis
20. Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene
21. A targeted chain-termination mutation in the mouse Apc gene results in multiple intestinal tumors
22. Molecular determinants of dysplasia in colorectal lesions
23. Aberrant crypt foci in colorectal carcinogenesis. Cell and crypt dynamics
24. Morphological and molecular processes of polyp formation in Apc(delta716) knockout mice
25. Apoptosis and APC in colorectal tumorigenesis
26. The adenomatous polyposis coil tumor suppressor protein localizes to plasma membrane sites involved in active cell migration
27. Forced expression of the tumor suppressor adenomatosis polyposis coli protein induces disordered cell migration in the intestinal epithelium
28. Wnt signaling in oncogenesis and embryogenesis - A look outside the nucleus
29. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC
30. Mutational analysis of the APC/catenin/Tcf pathway in colorectal cancer
31. The Yin-Yang of TOF/beta-catenin signaling
32. Wnt signaling and cancer
33. Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4
34. Differentiation therapy in acute myelogenous leukemia (non-APL)
35. Landscaping the cancer terrain
36. Molecular genetic characterization of both components of a dedifferentiated chondrosarcoma, with implications for its histogenesis
37. Is dedifferentiated chondrosarcoma a "de-differentiated" chondrosarcoma?
38. Cytogenetic polyclonality in tumors of the breast
39. Cytogenetic comparison of primary tumors and lymph node metastases in breast cancer patients